|
| GD-106-PHS-EMS: Transport Protocols |
Notice
of Agency Guidance Documents |
Guidance
Document |
Unpublished Notice (Publication in AAR is pending.) |
PDF |
| GD-101-PHS-EMS: Alternate Triage, Treatment and Transport Guidelines for Pandemic Influenza |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
17 AAR 1194 |
PDF |
|
| GD-097-PHS-EMS:
Triage, Treatment and Transport Guidelines |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
18 AAR 1716 |
PDF |
|
| GD-096-PHS-EMS:
Triage and Treatment Protocol for Pediatric Burn Injury |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 4425 |
[PDF] |
[WORD] |
|
| GD-087-PHS-EMS:
Cardiac Arrest Center Protocol |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 3505 |
[PDF] |
[WORD] |
| |
|
| GD-098-PHS-EMS: Curriculum for Helicopter Scene Safety – Arizona |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
17 AAR 90 |
[PDF] |
[Word] |
|
| GD-095-PHS-EMS:
Curriculum for the use of the Continuous Positive Airway Pressure Device (CPAP)
by the EMT-P |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 4424 |
[PDF] |
[WORD] |
|
| GD-094-PHS-EMS:
Training Curriculum for Automatic Transport Ventilator (ATV) |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 4424 |
[PDF] |
[WORD] |
|
| GD-092-PHS-EMS:
Curriculum for the Use of the Laryngeal Mask Airway (LMA)® |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 3509 |
[PDF] |
[WORD] |
|
| GD-088-PHS-EMS:
Curriculum for EMT-I and EMT-P Use of an EZ-IO drill device |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 3506 |
[PDF] |
[WORD] |
| back to top |
|
| GD-093-PHS-EMS:
Drug Profile for Ondansetron |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 4423 |
Drug Profile |
|
| GD-089-PHS-EMS:
Drug Profile for Epinephrine HCI (Revision of GD-040-PHS-EMS) |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
14
AAR 3506 |
Drug Profile |
|
| GD-086-PHS-EMS:
Drug Profile for Ranitidine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
13
AAR 597 |
Drug Profile |
|
| GD-085-PHS-EMS:
Drug Profile for Famotidine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
13
AAR 596 |
Drug Profile |
|
| GD-084-PHS-EMS:
Drug Profile for Cimetidine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
13
AAR 595 |
Drug Profile |
|
| GD-083-PHS-EMS: Drug Profile for Lorazepam |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
16 AAR 358 |
Drug Profile |
|
| GD-082-PHS-EMS:
Drug Profile for Racemic Epinephrine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
13
AAR 593 |
Drug Profile |
|
| GD-080-PHS-EMS:
Drug Profile for Vasopressin |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 4995 |
Drug Profile |
|
| GD-069-PHS-EMS:
Drug Profile for Succinylcholine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 3262 |
Drug Profile |
|
| GD-068-PHS-EMS:
Drug Profile for Etomidate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 3262 |
Drug Profile |
|
| GD-066-PHS-EMS:
Drug Profile for EMT-B Administration of Aspirin |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 2406 |
Drug Profile |
|
| GD-065-PHS-EMS:
Drug Profile for Epinephrine Auto-Injector |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 2405 |
Drug Profile |
|
| GD-063-PHS-EMS:
Drug Profile for Nalmefene
HCl |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-062-PHS-EMS:
Drug Profile for Total
Parenteral Nutrition |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-061-PHS-EMS:
Drug Profile for Tirofiban |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-060-PHS-EMS:
Drug Profile for Eptifibatide |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-059-PHS-EMS:
Drug Profile for Diltiazem |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-058-PHS-EMS:
Drug Profile for Albumin,
normal serum 5% or 25% |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-057-PHS-EMS:
Drug Profile for Abciximab |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-056-PHS-EMS:
Drug Profile for Verapamil
HCl |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-055-PHS-EMS:
Drug Profile for Thiamine
HCl (vitamin B1) |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-054-PHS-EMS:
Drug Profile for Sodium
Bicarbonate 8.4% > |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118> |
Drug Profile |
|
| GD-053-PHS-EMS:
Drug Profile for Phenylephrine
Nasal Spray 0.5% |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-052-PHS-EMS:
Drug Profile for Oxytocin |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-051-PHS-EMS:
Drug Profile for Nitrous
Oxide 50% |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-050-PHS-EMS:
Drug Profile for Nitroglycerin |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-049-PHS-EMS:
Drug Profile for Naloxone
HCl |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-048-PHS-EMS:
Drug Profile for Morphine
Sulfate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-047-PHS-EMS:
Drug Profile for Midazolam
Hydrochloride |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-046-PHS-EMS:
Drug Profile for Methylprednisolone
Sodium Succinate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-045-PHS-EMS: Drug Profile for Magnesium
Sulfate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
16 AAR 356 |
Drug Profile |
|
| GD-044-PHS-EMS:
Drug Profile for Lidocaine
HCl |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-043-PHS-EMS:
Drug Profile for Ipratropium
Bromide |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-042-PHS-EMS:
Drug Profile for Glucagon |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-041-PHS-EMS:
Drug Profile for Furosemide |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-039-PHS-EMS:
Drug Profile for Dopamine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-038-PHS-EMS:
Drug Profile for Diphenhydramine
HCl |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-037-PHS-EMS:
Drug Profile for Diazepam |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-036-PHS-EMS:
Drug Profile for Dextrose
50% |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-035-PHS-EMS:
Drug Profile for Dexamethasone
Sodium Phosphate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-034-PHS-EMS:
Drug Profile for Charcoal,
Activated (without sorbitol) |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-033-PHS-EMS:
Drug Profile for Calcium
Chloride |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-032-PHS-EMS:
Drug Profile for Bumetanide |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
| 17 AAR 630 |
|
|
| GD-030-PHS-EMS: Drug Profile for Atrophine
Sulfate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
16 AAR 355 |
Drug Profile |
|
| GD-029-PHS-EMS: Drug Profile for Amiodarone |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
15
AAR 940 |
Drug Profile |
|
| GD-028-PHS-EMS:
Drug Profile for Albuterol
Sulfate |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-027-PHS-EMS:
Drug Profile for Adenosine |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
|
| GD-026-PHS-EMS:
Drug Profile for Acetylsalicylic Acid, Aspirin, ASA |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 1118 |
Drug Profile |
| back to top |
|
|
| GD-104-PHS-EMS: Drug Shortages |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
17 AAR 2391 |
[PDF] |
[WORD] |
|
| GD-103-PHS-EMS: Criteria for Behavioral Health Situation Ambulance Transports |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
17 AAR 1364 |
[PDF] |
[WORD] |
|
| GD-102-PHS-EMS: Political Subdivision Contracts for Ambulance Service |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
18 AAR 1762 |
[PDF] |
|
| GD-099-PHS-EMS: Certificates of Necessity for Ambulance Service |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
17 AAR 6 |
[PDF] |
[WORD] |
|
| GD-081-PHS-EMS:
Recommendations for EMT-B Use of an Esophageal Tracheal Double Lumen Airway
Device (ETDLAD) |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 4995 |
[PDF] |
[WORD] |
|
| GD-067-PHS-EMS:
Recommendations for EMT-P Performance of Rapid Sequence Intubation (RSI)
in the Prehospital EMS Environment |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
11
AAR 3262 |
[PDF] |
[WORD] |
|
| GD-064-PHS-EMS: Recommendations for Safety and Operation of Air Ambulance Transportation |
| Notice
of Agency Guidance Documents |
Guidance
Document |
|
18 AAR 1760 |
[PDF] |
[WORD] |
| back to top |
